Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 4/20 | 0.59 |
| ▸ | PDE4A | P27815 | 3/20 | 0.59 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.59 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.59 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.59 |
| ▸ | ADORA2B | P29275 | 7/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.59 |
| ▸ | MTOR | P42345 | 8/20 | 0.48 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.48 |
| ▸ | GSK3A | P49840 | 1/20 | 0.48 |
| ▸ | JAK2 | O60674 | 1/20 | 0.48 |
| ▸ | JAK1 | P23458 | 1/20 | 0.48 |
| ▸ | JAK3 | P52333 | 1/20 | 0.48 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7295708 | 0.99 | ADORA2A (0.61) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7296248 | 0.96 | ADORA2A (0.61) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL6141778 | 0.93 | ADORA2A (0.64) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL31366236 | 0.84 | ADORA2A (0.59) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL29429682 | 0.80 | ADORA2A (0.49) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL27621962 | 0.80 | ADORA2B (0.66) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL10978398 | 0.78 | PDE4A (0.59) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7025705 | 0.77 | ADORA2B (0.55) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL27543834 | 0.76 | ADORA2B (0.97) | ADORA2APDE4APDE4BPDE4CPDE4D | |
| SCHEMBL7617653 | 0.76 | ADORA2B (0.50) | ADORA2AADORA2BADORA3MTORPIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0389282-B1 | Xanthinederivatives, process for their preparation and their pharmaceutical use | SMITHKLINE BEECHAM PHARMA GMBH (DE) | 2002-02-20 | — | — | EP | disclosed |